Page 207 - 2019_11 Resto del Mondo-web
P. 207

Christmas disease in a Hovawart family
Hepatology. 2010;51(2):642-653.
25. Weltmeier F, Borlak J. A high resolution genome-wide scan of HNF4alpha recogni- tion sites infers a regulatory gene network in
colon cancer. PLoS One. 2011;6(7):e21667.
26. Inoue Y, Peters LL, Yim SH, Inoue J, Gonzalez FJ. Role of hepatocyte nuclear fac- tor 4alpha in control of blood coagulation factor gene expression. J Mol Med (Berl).
2006;84(4):334-344.
27. Belvini D, Salviato R, Radossi P, et al.
Molecular genotyping of the Italian cohort of patients with hemophilia B. Haematologica. 2005;90(5):635-642.
28. Ghanem N, Costes B, Martin J, et al. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole fac- tor IX gene in a French population sample. Eur J Hum Genet. 1993;1(2):144-155.
29. Ketterling RP, Liu JZ, Liao D, et al. Two novel factor IX promoter mutations: incre- mental progress towards 'saturation in vivo mutagenesis' of a human promoter region. Hum Mol Genet. 1995;4(4):769-770.
30. Reijnen MJ, Peerlinck K, Maasdam D, Bertina RM, Reitsma PH. Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter. Blood. 1993;82 (1):151-158.
31. Heit JA, Ketterling RP, Zapata RE, Ordonez SM, Kasper CK, Sommer SS. Haemophilia B Brandenberg-type promoter mutation. Haemophilia. 1999;5(1):73-75.
32. Crossley M, Ludwig M, Stowell KM, De Vos P, Olek K, Brownlee GG. Recovery from hemophilia B Leyden: an androgen-respon- sive element in the factor IX promoter. Science. 1992;257(5068):377-379.
33. Pfeiffer I, Volkel I, Taubert H, Brenig B. Forensic DNA-typing of dog hair: DNA- extraction and PCR amplification. Forensic Sci Int. 2004;141(2-3):149-151.
34. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
35. Brown J, Pirrung M, McCue LA. FQC Dashboard: integrates FastQC results into a web-based, interactive, and extensible FASTQ quality control tool. Bioinformatics. 2017 Jun 9. [Epub ahead of print]
36. Lindblad-Toh K, Wade CM, Mikkelsen TS, et al. Genome sequence, comparative analy- sis and haplotype structure of the domestic dog. Nature. 2005;438(7069):803-819.
37. Burland TG. DNASTAR's Lasergene
sequence analysis software. Methods Mol
Biol. 2000;132:71-91.
38. Clewley JP. Macintosh sequence analysis
software. DNAStar's LaserGene. Mol
Biotechnol. 1995;3(3):221-224.
39. Jiang M, Li H, Zhang Y, et al. Transitional
basal cells at the squamous-columnar junc- tion generate Barrett's oesophagus. Nature. 2017;550(7677):529-533.
40. Lawson B, Robinson RA, Fernandez JR, et al. Spatio-temporal dynamics and aetiology of proliferative leg skin lesions in wild British finches. Sci Rep. 2018;8(1):14670.
41. Eggers C, Hook B, Lewis S, Strayer C, Landreman A. Designing a bioluminescent reporter assay: normalization. 2016 [cited 14.11.2018]; Available from: http://www.promega.de/resources/pub- hub/designing-a-bioluminescent-reporter- assay-normalization/
42. Dögel M. Working Dog. 2019 [cited 01.02.2019]; Available from: https://en.working-dog.com
43. Mischke R. [Comparison of factor VIII:C and factor IX sensitivity of different com- mercial APTT reagents for canine plasma]. Berl Munch Tierarztl Wochenschr. 1999;112(10-11):394-399.
44. Evans JP, Watzke HH, Ware JL, Stafford DW, High KA. Molecular cloning of a cDNA encoding canine factor IX. Blood. 1989;74 (1):207-212.
45. Bentley AK, Rees DJ, Rizza C, Brownlee GG. Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position -4. Cell. 1986;45(3):343-348.
46. Crossley M, Brownlee GG. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature. 1990;345(6274):444-446.
47. Mischke R. [Haemophilia A and B in dogs]. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2012;40(1):44-53; quiz 54.
48. Funnell AP, Wilson MD, Ballester B, et al. A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent vari- ant of hemophilia B Leyden. Am J Hum Genet. 2013;92(3):460-467.
49. Kurachi S, Huo JS, Ameri A, Zhang K, Yoshizawa AC, Kurachi K. An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden. Proc Natl Acad Sci U S A. 2009;106(19):7921-7926.
50. Reid KJ, Hendy SC, Saito J, Sorensen P, Nelson CC. Two classes of androgen recep- tor elements mediate cooperativity through
allosteric interactions. J Biol Chem. 2001;276
(4):2943-2952.
51. Wilson S, Qi J, Filipp FV. Refinement of the
androgen response element based on ChIP- Seq in androgen-insensitive and androgen- responsive prostate cancer cell lines. Sci Rep. 2016;6:32611.
52. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR. Prostate-specific antigen expression is regu- lated by an upstream enhancer. J Biol Chem. 1996;271(12):7043-7051.
53. Hildyard C, Keeling D. Effect of age on fac- tor IX levels in symptomatic carriers of haemophila B Leyden. Br J Haematol. 2015;169(3):448-449.
54. Naka H, Brownlee GG. Transcriptional reg- ulation of the human factor IX promoter by the orphan receptor superfamily factor, HNF4, ARP1 and COUP/Ear3. Br J Haematol. 1996;92(1):231-240.
55. Fang B, Mane-Padros D, Bolotin E, Jiang T, Sladek FM. Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors. Nucleic Acids Res. 2012;40(12):5343-5356.
56. Farre D, Roset R, Huerta M, et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003;31(13):3651-3653.
57. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. PROMO: detec- tion of known transcription regulatory ele- ments using species-tailored searches. Bioinformatics. 2002;18(2):333-334.
58. Fagerberg L, Hallstrom BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based pro- teomics. Mol Cell Proteomics. 2014;13(2): 397-406.
59. Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. Disruption of a binding site for hepato- cyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci U S A. 1992;89(14):6300-6303.
60. Morgan GE, Rowley G, Green PM, Chisholm M, Giannelli F, Brownlee GG. Further evidence for the importance of an androgen response element in the factor IX promoter. Br J Haematol. 1997;98(1):79-85.
61. Bennett RL, French KS, Resta RG, Doyle DL. Standardized human pedigree nomencla- ture: update and assessment of the recom- mendations of the National Society of Genetic Counselors. J Genet Couns. 2008;17(5):424-433.
haematologica | 2019; 104(11)
2313


































































































   205   206   207   208   209